NCT04585750 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) Status RECRUITING Phase PHASE1/PHASE2
NCT04574427 INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue Status COMPLETED Phase N/A
NCT04570839 COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. Status COMPLETED Phase PHASE1/PHASE2
NCT04566393 Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Status AVAILABLE Phase N/A
NCT04545632 Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor Status COMPLETED Phase N/A
NCT04543045 Qualitative Exploration of Head & Neck Cancer Patient Reported Experience of Radiotherapy Status UNKNOWN Phase N/A
NCT04541381 The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care Status SUSPENDED Phase NA
NCT04529850 Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT04517461 Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery Status COMPLETED Phase N/A
NCT04517019 Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy Status UNKNOWN Phase NA
NCT04510818 Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2) Status UNKNOWN Phase PHASE1
NCT04507035 Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy Status UNKNOWN Phase PHASE4
NCT04502797 A Feasibility Study to Evaluate The Effect of the Electronic Patient Visit Assessment On Pain and Quality of Life for Patients With Head and Neck Cancer (HNC) Status UNKNOWN Phase EARLY_PHASE1